M. Komoda

发表

Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients

K. Akashi, E. Baba, H. Kusaba, 2019, Gastric Cancer.

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer

K. Akashi, E. Baba, H. Kusaba, 2018, Gastric Cancer.

Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancer

K. Akashi, E. Baba, Mamoru Ito, 2017, Anti-cancer drugs.

Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment

K. Yamashita, N. Sugimoto, K. Ando, 2021, Frontiers in Oncology.

Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis

M. Morita, K. Sugimachi, Yoshiaki Fujimoto, 2021, Surgery Today.

Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)

K. Yamashita, N. Sugimoto, K. Ando, 2021, Frontiers in Oncology.

Systemic chemotherapy for metastatic non-mucinous appendiceal adenocarcinoma: a case report and literature review

K. Akashi, K. Tsuchihashi, E. Baba, 2012, International Cancer Conference Journal.

Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer

Yoshiyuki Yamamoto, K. Nagashima, T. Nakajima, 2021, BMC Cancer.

Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer

K. Akashi, K. Tsuchihashi, E. Baba, 2014, Medical Oncology.

Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report

K. Akashi, E. Baba, M. Nakamuta, 2015, Oncology letters.

Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.

K. Akashi, E. Baba, Y. Shibata, 2015, Anticancer research.

Mice lacking a transcriptional corepressor Tob are predisposed to cancer.

T. Noda, H. Satoh, S. Ishii, 2003, Genes & development.

Specific inhibitor of puromycin-sensitive aminopeptidase with a homophthalimide skeleton: identification of the target molecule and a structure-activity relationship study.

Y. Hashimoto, H. Takahashi, Y. Fujimoto, 2001, Bioorganic & medicinal chemistry.

Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer

I. Hyodo, Takanobu Yamada, Ken Kato, 2022, JCO precision oncology.

Efficacy and safety of an increased-dose of dexamethasone in patients receiving fosaprepitant chemotherapy in Japan.

K. Akashi, E. Baba, H. Kusaba, 2014, Asian Pacific journal of cancer prevention : APJCP.

Human STEAP3 maintains tumor growth under hypoferric condition.

K. Akashi, E. Baba, Taichi Isobe, 2011, Experimental cell research.

WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study).

K. Muro, Y. Hamamoto, K. Nagashima, 2022, Clinical colorectal cancer.

Pertuzumab plus trastuzumab and real-world standard of care (SOC) for patients (pts) with treatment refractory metastatic colorectal cancer (mCRC) with HER2 (ERBB2) amplification (amp) confirmed by tumor tissue or ctDNA analysis (TRIUMPH, EPOC1602).

S. Nomura, A. Sato, A. Ohtsu, 2021 .

Anti-HER2 combination chemotherapy for advanced gastric cancer associated with the Peutz-Jeghers syndrome: a case report and literature review

K. Akashi, E. Baba, Y. Oda, 2014, International Cancer Conference Journal.

Novel small molecule nonpeptide aminopeptidase n inhibitors with a cyclic imide skeleton.

Y. Koiso, R. Shirai, Y. Hashimoto, 1999, Journal of enzyme inhibition.

SAFETY AND TOLERABILITY OF VANDETANIB IN JAPANESE PATIENTS WITH MEDULLARY THYROID CANCER: A PHASE I/II OPEN-LABEL STUDY.

Yasuhiro Ito, A. Tsuji, T. Okamoto, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[Preparation of novel specific aminopeptidase inhibitors with a cyclic imide skeleton].

Y. Hashimoto, H. Takahashi, H. Kakuta, 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Methylation of drug resistance‐related genes in chemotherapy‐sensitive Epstein–Barr virus‐associated gastric cancer

K. Akashi, K. Tsuchihashi, E. Baba, 2019, FEBS open bio.

Biomarker study for trastuzumab continuation beyond progression in a randomized phase II trial of weekly paclitaxel±trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum (WJOG7112G).

I. Hyodo, K. Nishio, K. Muro, 2018 .

Successful Chemoradiotherapy for Undifferentiated Malignant Neoplasm Arising from the Left Pulmonary Artery

K. Akashi, E. Baba, Y. Oda, 2014, Case Reports in Oncology.

Survival in Older Japanese Adults With Advanced Cancer Before and After Implementation of a Geriatric Oncology Service

M. Morita, H. Muss, Y. Toh, 2023, JCO oncology practice.

Retrospective analysis of cardiovascular diseases related to chemotherapies for advanced solid tumor patients

K. Akashi, E. Baba, K. Odashiro, 2016, Anti-cancer drugs.

Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans

K. Akashi, K. Tsuchihashi, E. Baba, 2017, Molecular and clinical oncology.

Improvement of quality of life and survival using self-expandable metal stent placement for severe malignant stenosis of the gastric body: a case report

K. Akashi, E. Baba, Taichi Isobe, 2012, Journal of Medical Case Reports.

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan

K. Tsuchihashi, E. Baba, Taichi Isobe, 2023, BMC Cancer.

SAFETY AND TOLERABILITY OF VANDETANIB IN JAPANESE PATIENTS WITH MEDULLARY THYROID CANCER: A PHASE I/II OPEN-LABEL STUDY.

Yasuhiro Ito, A. Tsuji, T. Okamoto, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.